BNY Mellon Emerging Markets Fund
- TICKER MIEGX
- Fund Code 0908
- CUSIP 05569M848
- SHARE CLASS
-
Literature Download
Why invest in this Fund?
To pursue its goal, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies organized, or with a majority of assets or operations, in countries considered to be emerging markets. Normally, the fund will invest in a broad range of (and in any case at least five different) emerging market countries. The fund may invest in companies of any size.
The fund’s cash inflows are invested in equity securities of companies located in the foreign countries represented in the Morgan Stanley Capital International Emerging Markets (Free) Index (the “Index”).
The stocks purchased may have value and/or growth characteristics. The portfolio managers employ a bottom-up investment approach which emphasizes individual stock selection. The stock selection process is designed to produce a diversified portfolio that, relative to the MSCI Emerging Markets Index, has a below-average price/earnings ratio and an above-average earnings growth trend.
Morningstar Rating™ as of February 28, 2023 for the Investor Shares class shares; other classes may have different performance characteristics. Overall rating for the Diversified Emerging Markets category. Fund ratings are out of 5 Stars: Overall 3 Stars (742 funds rated); 3 Yrs. 3 Stars (742 funds rated); 5 Yrs. 2 Stars (657 funds rated); 10 Yrs. 3 Stars (395 funds rated). The Morningstar Rating™ for funds, or "star rating", is calculated for managed products with at least a 3-year history. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance (not including the effects of sales charges, loads and redemption fees if applicable), placing more emphasis on downward variations and rewarding consistent performance. Managed products; including open-end mutual funds, closed-end funds and exchange-traded funds; are considered a single population for comparative purposes. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its 3-, 5-, and 10-year (if applicable) Morningstar Rating metrics. © Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results. The fund represents a single portfolio with multiple share classes that have different expense structures. Other share classes may have achieved different results.
Portfolio Managers
-
Paul Birchenough
Co-Lead Portfolio Manager, Newton Investment Management Limited
Since October 2022
-
Ian Smith
Co-Lead Portfolio Manager, Newton Investment Management Limited
Since October 2022
-
Alex Khosla
Portfolio Manager, Newton Investment Management Limited
Since October 2022
Total Returns
Month End
Average Annual As of 02/28/23 |
|||||||
---|---|---|---|---|---|---|---|
Name |
3 MO 02/28/23 |
YTD 02/28/23 |
1 YR | 3 YRS | 5 YRS | 10 YRS | Since Inception |
BNY Mellon Emerging Markets Fund
MIEGX |
-1.44 | 1.90 | -16.32 | 1.56 | -2.24 | 1.18 | 7.14 |
MSCI Emerging Markets Index
|
-0.52 | 0.90 | -15.28 | 0.97 | -1.87 | 1.52 | - |
Quarter End
Average Annual As of 12/31/22 |
|||||||
---|---|---|---|---|---|---|---|
Name |
3 MO 12/31/22 |
YTD 12/31/22 |
1 YR | 3 YRS | 5 YRS | 10 YRS | Since Inception |
BNY Mellon Emerging Markets Fund
MIEGX |
10.27 | -21.71 | -21.71 | -2.48 | -1.93 | 0.98 | 7.11 |
MSCI Emerging Markets Index
|
9.70 | -20.09 | -20.09 | -2.69 | -1.40 | 1.44 | - |
The MSCI Emerging Markets Index is a free float-adjusted market capitalization-weighted index that is designed to measure equity market performance of emerging markets. Reflects reinvestment of net dividends and, where applicable, capital gain distributions. Investors cannot invest directly in any index.
Growth of $10,000 Investment
Historical Performance
Yearly Total Return
Yearly
Prospectus Fee Table Expense Ratios
As of 12/30/22 Fee Description | Expense Ratio (%) |
---|---|
Management Fee | 1.15% |
Service Fee | 0.25% |
Administration Fee | 0.13% |
Other Expenses | 0.15% |
Total Expenses | 1.68% |
Portfolio Manager/Sub-Investment Adviser
Asset Allocation
Daily Statistics
As of 03/24/23 Name | NAV | Change |
04/04/22 12 Month High Nav |
12/28/22 12 Month Low Nav |
YTD Return |
---|---|---|---|---|---|
MIEGX
|
$9.74 |
-$0.01
-0.10%
|
$13.05 | $9.46 | 2.53% |
Performance Metrics
Overall Morningstar Rating
MORNINGSTAR CATEGORY Diversified Emerging Markets
Morningstar Rating™ as of 02/28/23 for the Investor Shares shares; other classes may have different performance
characteristics. Overall rating for the Diversified Emerging Markets. Fund ratings are out of 5 Stars: Overall
3 Stars (742 funds rated); 3 Yrs.
3 Stars (742 funds rated); 5 Yrs.
2 Stars (657 funds rated); 10 Yrs.
3 Stars (395 funds rated).
The
Morningstar Rating™ for funds, or "star rating", is calculated for managed products with at least a 3-year history. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for
variation in a managed product's monthly excess performance (not including the effects of sales charges, loads and redemption fees if applicable), placing more emphasis on downward variations and rewarding
consistent performance. Managed products; including open-end mutual funds, closed-end funds and exchange-traded funds; are considered a single population for comparative purposes. The top 10% of products in
each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a
managed product is derived from a weighted average of the performance figures associated with its 3-, 5-,and 10-year (if applicable) Morningstar Rating metrics. ©
Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be
accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future
results. The fund represents a single portfolio with multiple share classes that have different expense structures. Other share classes may have achieved different results.
Lipper Rankings
-
1 Year
531 out of 789 -
3 Year
257 out of 705 -
5 Year
372 out of 618 -
10 Year
208 out of 369
LIPPER CLASSIFICATION
Main Risks
The fund's performance will be influenced by political, social and economic factors affecting investments in foreign issuers. These special risks include exposure to currency fluctuations, less liquidity, less developed or less efficient trading markets, lack of comprehensive company information, political and economic instability and differing auditing and legal standards. Investments denominated in foreign currencies are subject to the risk that those currencies will decline in value relative to the U.S. dollar, or, in the case of hedged positions, that the U.S. dollar will decline relative to the currency being hedged.
Emerging markets tend to be more volatile and less liquid than the markets of more mature economies, and generally have less diverse and less mature economic structures and less stable political systems than those of developed countries.
Please refer to the prospectus for a more complete discussion of the fund's main risks.conomic structures and less stable political systems than those of developed countries.
Please refer to the prospectus for a more complete discussion of the fund's main risks.
Recent market risks include pandemic risks related to COVID-19. The effects of COVID-19 have contributed to increased volatility in global markets and will likely affect certain countries, companies, industries and market sectors more dramatically than others. To the extent the fund may overweight its investments in certain countries, companies, industries or market sectors, such positions will increase the fund's exposure to risk of loss from adverse developments affecting those countries, companies, industries or sectors.
Risk Metrics
As of 02/28/23 3-Year Trailing | Standard Deviation | Alpha | Beta | R-Squared | Sharpe Ratio |
---|---|---|---|---|---|
MIEGX
|
22.38 | -3.22 | 1.04 | 82.62 | 0.14 |
All risk metrics are provided by Morningstar. The index used in the calculations are determined by Morningstar which may not be the funds primary benchmark. The index Morningstar used for this analysis is MSCI ACWI ex USA Index.
Dividend Schedule
Year | Dividend ($) | Capital Gains ($) |
---|---|---|
2022 | 1.2459 | 0.0000 |
2021 | 0.2431 | 0.0000 |
2020 | 0.1279 | 0.0000 |
2019 | 0.1074 | 0.0000 |
2018 | 0.0489 | 0.0000 |
2017 | 0.0720 | 0.0000 |
2016 | 0.0500 | 0.0000 |
2015 | 0.0370 | 0.0000 |
2014 | 0.1150 | 0.0000 |
2013 | 0.0830 | 0.0000 |
Distributions History
Record Date | Ex-Dividend Date | Payable Date |
Ordinary Non-Qualified Dividends |
Qualified Dividends |
Non-Qualified Short-Term Capital Gain |
Qualified Short-Term Capital Gain |
Long-Term Capital Gain |
Total Distribution |
Reinvest NAV |
---|---|---|---|---|---|---|---|---|---|
12/13/22 | 12/14/22 | 12/14/22 | 0.4151 | 0.8308 | 0.0000 | 0.0000 | 0.0000 | 1.2459 | 9.72 |
Record Date | Ex-Dividend Date | Payable Date |
Ordinary Non-Qualified Dividends |
Qualified Dividends |
Non-Qualified Short-Term Capital Gain |
Qualified Short-Term Capital Gain |
Long-Term Capital Gain |
Total Distribution |
Reinvest NAV |
---|---|---|---|---|---|---|---|---|---|
12/14/21 | 12/15/21 | 12/15/21 | 0.0000 | 0.2431 | 0.0000 | 0.0000 | 0.0000 | 0.2431 | - |
12/14/20 | 12/15/20 | 12/15/20 | 0.0170 | 0.1109 | 0.0000 | 0.0000 | 0.0000 | 0.1279 | - |
12/12/19 | 12/13/19 | 12/13/19 | 0.0000 | 0.1074 | 0.0000 | 0.0000 | 0.0000 | 0.1074 | - |
12/12/18 | 12/13/18 | 12/13/18 | 0.0000 | 0.0489 | 0.0000 | 0.0000 | 0.0000 | 0.0489 | - |
12/13/17 | 12/14/17 | 12/14/17 | 0.0000 | 0.0720 | 0.0000 | 0.0000 | 0.0000 | 0.0720 | - |
12/14/16 | 12/15/16 | 12/15/16 | 0.0000 | 0.0500 | 0.0000 | 0.0000 | 0.0000 | 0.0500 | - |
12/15/15 | 12/16/15 | 12/16/15 | 0.0000 | 0.0370 | 0.0000 | 0.0000 | 0.0000 | 0.0370 | - |
12/16/14 | 12/17/14 | 12/17/14 | 0.0000 | 0.1150 | 0.0000 | 0.0000 | 0.0000 | 0.1150 | - |
12/17/13 | 12/18/13 | 12/18/13 | 0.0000 | 0.0830 | 0.0000 | 0.0000 | 0.0000 | 0.0830 | - |
12/18/12 | 12/19/12 | 12/19/12 | 0.0000 | 0.0690 | 0.0000 | 0.0000 | 0.0000 | 0.0690 | - |
12/19/11 | 12/20/11 | 12/20/11 | 0.0000 | 0.0946 | 0.0000 | 0.0000 | 0.3113 | 0.4059 | - |
12/20/10 | 12/21/10 | 12/21/10 | 0.0000 | 0.0400 | 0.0000 | 0.0000 | 0.0000 | 0.0400 | - |
See all rows... |
Literature
Factsheet, Prospectus and Reports
- Download
- Share
- Subscribe
- Order